SS18L2P1

RNA — tumor vs normal
Tumor vs NormalRNABox plot · TCGA cohorts

Across TCGA pan-cancer cohorts, SS18L2P1 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of SS18L2P1’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where SS18L2P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SS18L2P1 is over-expressed in tumor.

UCEC and KIRP are the cancer types where SS18L2P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SS18L2P1 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.
LineageGenderStageFold-changepSampling consensus
UCECAllAll+0.254.0056view →
KIRPFemaleAll+0.112.0261view →
Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

SS18L2P1–UCEC

Tumor-vs-normal expression box plot for SS18L2P1 RNA in UCEC.

Open the UCEC breakdown →

Exploration